Results 31 to 40 of about 77,933 (251)

Dental and Oral Lesions in HIV-Positive Individuals in East Bohemia – Czech Republic, Single Centre Experience

open access: yesActa Medica, 2016
Background: Human immunodeficiency virus (HIV) continues to be a serious health issue and one of the world most devastating epidemics. An estimated 1.5 million people died from AIDS-related illnesses in 2013, and an estimated 37 million people with AIDS ...
Martin Šembera   +2 more
doaj   +1 more source

Thalidomide: an emerging drug in oral mucosal lesions [PDF]

open access: yesClinical Journal of Gastroenterology, 2009
Thalidomide has reemerged as a potential drug with new found uses despite its history of having caused devastating congenital birth defects. The drug has become the subject of major interest because of its clinical value in certain clearly defined disorders.
K, Mubeen, M Ahmed, Siddiq, V R, Jigna
openaire   +2 more sources

Regulation of the lncRNA NEAT1 by p53‐ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC

open access: yesMolecular Oncology, EarlyView.
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico   +5 more
wiley   +1 more source

Prevalence of oral mucosal lesions and variations in Indian public school children

open access: yesBrazilian Journal of Oral Sciences, 2015
Aim: To study the nature and distribution of oral mucosal lesions and variations in children. Methods: This investigation was a cross-sectional study. All the study subjects were taken from government primary school.
Ambika L.   +3 more
doaj   +1 more source

Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study.

open access: yesPLoS ONE, 2019
BackgroundChronic kidney disease is a risk factor for oral diseases, which may be associated with premature death. We evaluated the risk of all-cause and cardiovascular mortality associated with oral mucosal lesions in adults with kidney failure treated ...
Marinella Ruospo   +26 more
doaj   +1 more source

Oral Mucosal Lesions

open access: yesThe Journal of The Korean Dental Association, 2017
A wide variety of benign and malignant lesions and other diseases can develop on oral mucosa. Oral mucosal lesions can also be associated with an underlying systemic disease, so their correct diagnosis, which may even share similar clinical and demographic features, is always a challenge for a dentist.
openaire   +1 more source

Biodegradable and Biocompatible Functional Polymers for Biomedical Applications

open access: yesAdvanced Functional Materials, EarlyView.
Biodegradable and biocompatible functional polymers integrate electrical, mechanical, and stimuli‐responsive functionalities while enabling programmed degradation under physiological conditions. This review introduces recent advances in conductive, shape‐memory, self‐healing, photocurable, and adhesive polymer systems, emphasizing material design ...
Won Bae Han   +5 more
wiley   +1 more source

Periodontal health status, oral mucosal lesions, and adverse oral habits among rubber factory workers of Bahadurgarh, Haryana, India

open access: yesIndian Journal of Dental Sciences, 2019
Objective: The objective of this study was to assess the prevalence of periodontal disease, oral mucosal lesions, and tobacco usage among rubber factory workers of Bahadurgarh, Haryana, India.
Savita Solanki   +5 more
doaj   +1 more source

Prevalence of oromucosal lesions in HIV positive patients receiving haart-A prospective clinical study

open access: yesJournal of Family Medicine and Primary Care, 2020
Aim: To determine the preponderance of oral mucosal lesions and conditions in patients receiving highly active antiretroviral therapy (HAART) for Human Immunodeficiency virus (HIV).
Saritha Maloth   +3 more
doaj   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy